1. Giavina-Bianchi P, Aun MV, Galvão VR, Castells M. Rapid Desensitization in Immediate Hypersensitivity Reaction to Drugs. Curr Treat Options Allergy. 2015; 2:268‑85.

2. Sancho-Serra MDC, Simarro M, Castells M. Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcεRI internalization. Eur J Immunol. 2011;41:1004‑13.

3. Andrews NL, Pfeiffer JR, Martinez AM, Haaland DM, Davis RW, Kawakami T, et al. Small, mobile FceRI receptor aggregates are signaling competent. Immunity. 2009;31:469‑79.

4. Oka T, Rios EJ, Tsai M, Kalesnikoff J, Galli SJ. Rapid desensitization induces internalization of antigenspecific IgE on mouse mast cells. J Allergy Clin Immunol. 2013:1‑27.

5. Novak N, Mete N, Bussmann C, Maintz L, Bieber T, Akdis M, et al. Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2. J Allergy Clin Immunol. 2012;130:1153‑1158.e2.

6. Castells MC, Tennant NM, Sloane DE, Ida Hsu F, Barrett NA, Hong DI, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008;122:574‑80.

7. Brennan PJ, Rodriguez Bouza T, Hsu FI, Sloane DE, Castells MC. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol. 2009;124:1259‑66.

8. Cernadas JR, Brockow K, Romano A, Aberer W, Torres MJ, Bircher A, et al. General considerations on rapid desensitization for drug hypersensitivity – a consensus statement. Allergy. 2010;65:1357‑66.

9. Castells MC. Anaphylaxis to chemotherapy and monoclonal antibodies. Immunol Allergy Clin North Am. 2015;35:335‑48.

10. Mezzano V, Giavina-Bianchi P, Picard M, Caiado J, Castells M. Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy. BioDrugs. 2014;28:133‑44.

11. Giavina-Bianchi P, Caiado J, Picard M, Pur Ozyigit L, Mezzano V, Castells M, et al. Rapid desensitization to chemotherapy and monoclonal antibodies is effective and safe. Allergy. 2013;68:1482‑4.

12. Madrigal-Burgaleta R, Berges-Gimeno MP, Angel Pereira D, FerreiroMonteagudo R, Guillen-Ponce C, Pueyo C, et al. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment. Allergy. 2013;68:853‑61.

13. Doña I, Barrionuevo E, Blanca-Lopez N, Torres MJ, Fernandez TD, Mayorga C, et al. Trends in hypersensitivity drug reactions: more drugs, more response patterns, more heterogeneity. J Investig Allergol Clin Immunol. 2014;24:143-53.

14. Mirakian R, Leech SC, Krishna MT, Richter AG, Huber PAJ, Farooque S, et al. Management of allergy to penicillins and other beta-lactams. Clin Exp Allergy. 2015;45:300-27.

15. Torres MJ, Blanca M. The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams. Med Clin North Am. 2010;94:805‑20.

16. Borish L, Tamir R, Rosenwasser LJ. Intravenous desensitization to betalactam antibiotics. J Allergy Clin Immunol. 1987;80(3Pt1):314‑9.

17. Castells Guitart MC. Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century. J Investig Allergol Clin Immunol. 2014;24:72‑9.

18. Garcia JFB, Aun MV, Garro LS, Kalil J, Motta AA, Giavina-Bianchi P. Risk stratification for penicillin desensitization in allergic pregnant women with syphilis. In: AAAAI, 2017, Atlanta. J Allergy Clin Immunol. 2017;139:31.

19. Garcia JFB, Aun MV, Garro LS, Giavina-Bianchi P, Kalil J, Motta AA. Risk stratification for penicillin desensitization in allergic pregnant women with syphilis. Abstract of the EAACI; 2016; Vienna. J Allergy Clin Immunol. 2017;139(2):Suppl. AB31.

20. Scherer K, Brockow K, Aberer W, Gooi JHC, Demoly P, Romano A, et al. Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group. Allergy. 2013;68:844‑52.